nView s1 Pediatric Commercialization

About nView Medical

nView Medical is a commercial-stage medical device company that has developed an integrated 3D imaging and surgical navigation platform, the nView s1™. The system combines low-dose 3D imaging, real-time instrument tracking ('True-Map Navigation™'), and AI to provide intraoperative planning and guidance, primarily for spinal and orthopedic surgeries. With FDA 510(k) clearance secured in 2021, the company has begun commercialization, marked key partnerships, and reported over 500 surgeries performed as of early 2025. The leadership team boasts extensive experience from GE Healthcare and other major medtech firms, driving the company's mission to improve surgical outcomes.

Therapeutic Areas